- Home
- NTIC vs CRVO Comparison
NTIC vs CRVO Comparison
Compare NTIC & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- CRVO
- Stock Information
- Founded
- NTIC 1970
- CRVO 2001
- Country
- NTIC United States
- CRVO United States
- Employees
- NTIC N/A
- CRVO N/A
- Industry
- NTIC Industrial Specialties
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- NTIC Industrials
- CRVO Health Care
- Exchange
- NTIC Nasdaq
- CRVO Nasdaq
- Market Cap
- NTIC 121.6M
- CRVO 98.3M
- IPO Year
- NTIC N/A
- CRVO N/A
- Fundamental
- Price
- NTIC $12.90
- CRVO $2.11
- Analyst Decision
- NTIC Buy
- CRVO Buy
- Analyst Count
- NTIC 1
- CRVO 8
- Target Price
- NTIC $20.00
- CRVO $38.75
- AVG Volume (30 Days)
- NTIC 26.0K
- CRVO 303.4K
- Earning Date
- NTIC 01-08-2025
- CRVO 11-12-2024
- Dividend Yield
- NTIC 2.17%
- CRVO N/A
- EPS Growth
- NTIC 52.91
- CRVO N/A
- EPS
- NTIC 0.52
- CRVO N/A
- Revenue
- NTIC $86,216,235.00
- CRVO $10,066,550.00
- Revenue This Year
- NTIC $11.04
- CRVO $34.17
- Revenue Next Year
- NTIC $8.10
- CRVO N/A
- P/E Ratio
- NTIC $24.81
- CRVO N/A
- Revenue Growth
- NTIC 7.59
- CRVO 116.29
- 52 Week Low
- NTIC $11.70
- CRVO $1.80
- 52 Week High
- NTIC $19.63
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- NTIC 43.11
- CRVO 28.68
- Support Level
- NTIC $12.70
- CRVO $2.03
- Resistance Level
- NTIC $13.41
- CRVO $2.17
- Average True Range (ATR)
- NTIC 0.62
- CRVO 0.16
- MACD
- NTIC -0.05
- CRVO 0.30
- Stochastic Oscillator
- NTIC 26.67
- CRVO 23.08
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.